MX2017006168A - Composiciones. - Google Patents
Composiciones.Info
- Publication number
- MX2017006168A MX2017006168A MX2017006168A MX2017006168A MX2017006168A MX 2017006168 A MX2017006168 A MX 2017006168A MX 2017006168 A MX2017006168 A MX 2017006168A MX 2017006168 A MX2017006168 A MX 2017006168A MX 2017006168 A MX2017006168 A MX 2017006168A
- Authority
- MX
- Mexico
- Prior art keywords
- hpc
- wax
- core
- delayed release
- coated tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una tableta revestida en prensa para liberación retardada de un ingrediente activo que comprende: (a) un núcleo que comprende uno o más ingredientes activos, y; (b) una barrera de liberación retardada erosionable que circunda el núcleo y que comprende una cera y dos o más grados de LHPC, en donde la cera y L-HPC se proporcionan en una relación en peso de cera a L-HPC de 30%:70% a 70%:30%. La invención también se refiere a un método para hacer la tableta revestida en prensa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1420306.1A GB201420306D0 (en) | 2014-11-14 | 2014-11-14 | Compositions |
| PCT/GB2015/053471 WO2016075495A1 (en) | 2014-11-14 | 2015-11-16 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017006168A true MX2017006168A (es) | 2017-09-12 |
Family
ID=52248394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017006168A MX2017006168A (es) | 2014-11-14 | 2015-11-16 | Composiciones. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10675247B2 (es) |
| EP (1) | EP3217964B1 (es) |
| JP (1) | JP6774103B2 (es) |
| KR (1) | KR102253728B1 (es) |
| CN (1) | CN106999438A (es) |
| AU (1) | AU2015344838B2 (es) |
| CA (1) | CA2967738C (es) |
| DK (1) | DK3217964T3 (es) |
| ES (1) | ES2755960T3 (es) |
| GB (1) | GB201420306D0 (es) |
| HK (1) | HK1244432A1 (es) |
| HU (1) | HUE047581T2 (es) |
| MX (1) | MX2017006168A (es) |
| PL (1) | PL3217964T3 (es) |
| PT (1) | PT3217964T (es) |
| RU (1) | RU2717574C2 (es) |
| SA (1) | SA517381522B1 (es) |
| SI (1) | SI3217964T1 (es) |
| WO (1) | WO2016075495A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201420311D0 (en) * | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
| US11571391B2 (en) * | 2018-01-09 | 2023-02-07 | Triastek, Inc. | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant |
| WO2023214280A1 (en) * | 2022-05-06 | 2023-11-09 | Craft Health Pte Ltd | System for controllable release in 3d-printed colon targeting (corr3ct) oral dosage form |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132753A (en) | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
| JPS5839618A (ja) | 1981-09-04 | 1983-03-08 | Chugai Pharmaceut Co Ltd | 持続性積層錠剤 |
| US4443428A (en) | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
| US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| US5126145A (en) | 1989-04-13 | 1992-06-30 | Upsher Smith Laboratories Inc | Controlled release tablet containing water soluble medicament |
| EP0418596A3 (en) | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
| AU3949093A (en) | 1992-03-31 | 1993-11-08 | Benzon Pharma A/S | A pharmaceutical formulation |
| JP3059004B2 (ja) * | 1992-09-18 | 2000-07-04 | ダイセル化学工業株式会社 | アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法 |
| US5690959A (en) | 1993-05-29 | 1997-11-25 | Smithkline Beecham Corporation | Pharmaceutical thermal infusion process |
| IL109770A0 (en) | 1993-05-29 | 1994-11-28 | Smithkline Beecham Corp | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
| US5451409A (en) * | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
| JPH07223970A (ja) * | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
| ES2274625T3 (es) | 1998-05-18 | 2007-05-16 | Takeda Pharmaceutical Company Limited | Comprimidos desintegrables en la boca que comprenden un bencimidazol. |
| CA2348871C (en) | 1998-11-02 | 2009-04-14 | John G. Devane | Multiparticulate modified release composition |
| US6340478B1 (en) | 1999-06-07 | 2002-01-22 | Bio Dar Ltd. | Microencapsulated and controlled-release herbal formulations |
| US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| IN190974B (es) * | 1999-09-10 | 2003-09-06 | Ranbaxy Lab Ltd | |
| AU6589200A (en) | 1999-09-10 | 2001-04-17 | Ranbaxy Laboratories Limited | Extended release formulation of etodolac |
| MXPA02004293A (es) | 1999-10-29 | 2002-10-31 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada.. |
| WO2001054671A1 (fr) | 2000-01-27 | 2001-08-02 | Tanabe Seiyaku Co., Ltd. | Preparation a liberation prolongee et son procede de fabrication |
| JP4817562B2 (ja) * | 2001-09-26 | 2011-11-16 | 東和薬品株式会社 | 長時間持続型ニフエジピン有核錠 |
| JP2003171277A (ja) * | 2001-12-07 | 2003-06-17 | Wyeth Lederle Japan Ltd | 薬物放出時間制御型固形製剤 |
| RU2391093C2 (ru) | 2003-04-24 | 2010-06-10 | Джаготек Аг | Таблетка замедленного высвобождения с заданной геометрией ядра |
| US20040241234A1 (en) * | 2003-06-02 | 2004-12-02 | Alpharma, Inc. | Controlled release press-coated formulations of water-soluble active agents |
| US6869963B2 (en) * | 2003-07-11 | 2005-03-22 | Sandoz Ag | Stable pharmaceutical compositions containing an ACE inhibitor |
| WO2005041935A1 (en) | 2003-10-21 | 2005-05-12 | Alpharma, Inc. | Pharmaceutical formulations containing quetiapine |
| US20050152974A1 (en) | 2003-12-31 | 2005-07-14 | Garth Boehm | Atomoxetine formulations |
| US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
| WO2006017159A1 (en) | 2004-07-09 | 2006-02-16 | Drugtech Corporation | Controlled phase composition technology as an improved process for protection of drugs |
| EP1793808A1 (en) | 2004-09-29 | 2007-06-13 | Aurobindo Pharma Limited | Solid unit dosage forms of 5-ht1 agonist |
| US20070129402A1 (en) | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
| EP1942875B1 (en) | 2005-08-24 | 2015-08-12 | Rubicon Research Private Limited | Controlled release formulation |
| BRPI0712532A2 (pt) * | 2006-06-01 | 2013-04-02 | Schering Plough Healthcare Prod Inc | formulaÇÕes e composiÇÕes farmacÊuticas de fenilefrina para absorÇço colânica |
| KR100812538B1 (ko) | 2006-10-23 | 2008-03-11 | 한올제약주식회사 | 약물 제어방출형 메트포르민-글리메피리드 복합제제 |
| US9833510B2 (en) | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
| US20100316711A1 (en) * | 2007-10-25 | 2010-12-16 | Bayer Yakuhin ,Ltd. | Nifedipine containing opress coated tablet and method of preparing same |
| JP4329947B1 (ja) * | 2009-01-20 | 2009-09-09 | ライオン株式会社 | 内服用錠剤 |
| GB201003734D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
| GB201003731D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
| GB201003766D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Pulsatile drug release |
| CN103690545A (zh) * | 2013-11-27 | 2014-04-02 | 河南中帅医药科技股份有限公司 | 口服泼尼松择时释放制剂及其制备方法 |
| GB201420311D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
| GB201420300D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Tablet |
-
2014
- 2014-11-14 GB GBGB1420306.1A patent/GB201420306D0/en not_active Ceased
-
2015
- 2015-11-16 US US15/526,655 patent/US10675247B2/en active Active
- 2015-11-16 AU AU2015344838A patent/AU2015344838B2/en active Active
- 2015-11-16 CN CN201580065549.1A patent/CN106999438A/zh active Pending
- 2015-11-16 PL PL15797173T patent/PL3217964T3/pl unknown
- 2015-11-16 HU HUE15797173A patent/HUE047581T2/hu unknown
- 2015-11-16 MX MX2017006168A patent/MX2017006168A/es unknown
- 2015-11-16 RU RU2017116588A patent/RU2717574C2/ru active
- 2015-11-16 PT PT157971730T patent/PT3217964T/pt unknown
- 2015-11-16 EP EP15797173.0A patent/EP3217964B1/en active Active
- 2015-11-16 KR KR1020177016405A patent/KR102253728B1/ko active IP Right Grant
- 2015-11-16 DK DK15797173T patent/DK3217964T3/da active
- 2015-11-16 JP JP2017545002A patent/JP6774103B2/ja active Active
- 2015-11-16 ES ES15797173T patent/ES2755960T3/es active Active
- 2015-11-16 CA CA2967738A patent/CA2967738C/en active Active
- 2015-11-16 SI SI201530991T patent/SI3217964T1/sl unknown
- 2015-11-16 WO PCT/GB2015/053471 patent/WO2016075495A1/en active Application Filing
-
2017
- 2017-05-14 SA SA517381522A patent/SA517381522B1/ar unknown
-
2018
- 2018-03-20 HK HK18103847.9A patent/HK1244432A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3217964B1 (en) | 2019-09-04 |
| BR112017010070A2 (pt) | 2018-01-02 |
| HUE047581T2 (hu) | 2020-05-28 |
| JP6774103B2 (ja) | 2020-10-21 |
| AU2015344838A1 (en) | 2017-06-01 |
| CN106999438A (zh) | 2017-08-01 |
| AU2015344838B2 (en) | 2020-10-08 |
| WO2016075495A1 (en) | 2016-05-19 |
| US10675247B2 (en) | 2020-06-09 |
| GB201420306D0 (en) | 2014-12-31 |
| KR102253728B1 (ko) | 2021-05-21 |
| RU2017116588A (ru) | 2018-12-14 |
| SI3217964T1 (sl) | 2020-02-28 |
| HK1244432A1 (zh) | 2018-08-10 |
| PL3217964T3 (pl) | 2020-03-31 |
| SA517381522B1 (ar) | 2021-04-06 |
| KR20170084282A (ko) | 2017-07-19 |
| RU2017116588A3 (es) | 2019-06-18 |
| JP2017534688A (ja) | 2017-11-24 |
| ES2755960T3 (es) | 2020-04-24 |
| EP3217964A1 (en) | 2017-09-20 |
| PT3217964T (pt) | 2019-11-26 |
| CA2967738A1 (en) | 2016-05-19 |
| US20170333355A1 (en) | 2017-11-23 |
| CA2967738C (en) | 2021-07-06 |
| RU2717574C2 (ru) | 2020-03-24 |
| DK3217964T3 (da) | 2019-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016014320A (es) | Composiciones de suspension de liberacion prolongada. | |
| MX2018005639A (es) | Composicion de recubrimiento de semilla. | |
| EA201501024A1 (ru) | Составы с замедленным высвобождением, содержащие колхицин, и способы их применения | |
| MX2019001121A (es) | Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion. | |
| PH12017502376B1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| MY184650A (en) | Antioxidant composition for oil, preparation method therefor, cooking oil containing same, and method for preparing cooking oil | |
| MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
| MD4563B1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| PH12017500563A1 (en) | Stabilized adrenomedullin derivatives and use thereof | |
| PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| MX2017006168A (es) | Composiciones. | |
| EP3646855A4 (en) | COMPOSITION FOR SOLID PREPARATION FOR ORAL USE INCLUDING A PROTON PUMP INHIBITOR, SOLID PREPARATION FOR ORAL USE INCLUDING IT, AND PROCESS FOR PREPARATION | |
| MX2017013278A (es) | Odorante osmanthus. | |
| WO2013170086A3 (en) | Formulations for the delivery of active ingredients | |
| EP3144005A4 (en) | Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof | |
| PH12017501767A1 (en) | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | |
| GR20150100035A (el) | Φαρμακευτικο σκευασμα περιεχον απρεπιταντη και μεθοδος παρασκευης αυτου | |
| MA39009A (fr) | Compositions pharmaceutiques comprenant un agent actif | |
| EP3135299A4 (en) | Active ingredient (i) containing composition and method for preparing same | |
| WO2020055359A3 (en) | Oral dosage form of sorafenib tosylate | |
| MX2019015869A (es) | Nuevas formulaciones orales de belinostat. | |
| EP3624809A4 (en) | PHARMACEUTICAL AGENTS, COMPOSITIONS AND RELATED PROCESSES | |
| MX2018007977A (es) | Forma farmaceutica osmotica de liberacion extendida que contiene una carga de clorhidrato de metilfenidato alta. | |
| MX2018008376A (es) | Composiciones de fragancia de liberacion prolongada. |